Anzeige
Mehr »
Dienstag, 17.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 853081 | ISIN: US0010551028 | Ticker-Symbol: AFL
Tradegate
16.02.26 | 15:38
97,44 Euro
+0,41 % +0,40
1-Jahres-Chart
AFLAC INC Chart 1 Jahr
5-Tage-Chart
AFLAC INC 5-Tage-Chart
RealtimeGeldBriefZeit
96,7097,3616.02.
96,7097,3616.02.
ACCESS Newswire
479 Leser
Artikel bewerten:
(2)

Aflac Incorporated: From Patient to Lifelong Inspiration: Aflac Employee Cyronn Herrington Shares His Powerful Story of Living With Hemophilia B

Originally published on Aflac Newsroom

NORTHAMPTON, MA / ACCESS Newswire / September 2, 2025 / Aflac employee Cyronn Herrington had a unique childhood, starting at birth. He was diagnosed with hemophilia B, a chronic bleeding disorder that keeps blood from clotting properly.

"I had to always be in some form of a bubble," said Cyronn. "I couldn't do certain physical activities, no sports or anything like that."

Bleeds can occur at any time, anywhere, but especially in target joints - a place in the body where bleeding is most likely to occur. For Cyronn, his target joint is his right knee. In 2009, he injured it at a summer camp when he fell off a bicycle.

Neither Cyronn nor his parents had any idea at the time what an impact this injury would have. Later that year, Cyronn needed a wheelchair or crutches, and he underwent several surgeries from 2009 to 2014.

One of these surgeries brought him to the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, a national leader in pediatric cancer and blood disorders treatment and research. The surgery resulted in a loss of blood flow between his knee and foot due to shrunken arteries in his leg after years of immobilization. Ultimately, he lost his leg at 14 years old and spent three months recovering at the Aflac Cancer and Blood Disorders Center.

While Cyronn recovered from his surgery, the Aflac Cancer and Blood Disorders Center offered many great experiences which helped shine a bright light on the road ahead, including meeting the Ole Miss football team, various musical artists and frequent opportunities to work with therapy dogs.

According to Cyronn, an important part of the recovery process is staying positive. That is the advice he received as a patient and would impart to anyone in a similar situation. "At the center, I was treated with a lot of respect - they really understood me," he said. "They encouraged me to stay focused on the end goal, and that's what I like to tell others: What you don't do is give up or stop believing in yourself."

Cyronn continued his journey at the the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta until 2021, when he transferred to the adult clinic at Emory Healthcare in Atlanta. His connection with Aflac, however, had only just begun.

After a lifelong passion for computing and IT, Cyronn earned his bachelor's degree in Information Technology from Middle Georgia State University. He applied for an internship with Aflac, where he began his IT career with the Project Portfolio Management team. Cyronn has been part of Aflac ever since, now working as a Data Engineer with the Data Tools Administration team.

Cyronn also likes to give back, dedicating his time to working with children with hemophilia as a camp counselor at Camp Wannaklot, where he has been a counselor for the past seven years after attending several years as a camper. He also recently shared his story at the Care-A-Thon fundraising event benefiting the Aflac Cancer and Blood Disorders Center.

Camp Wannaklot helps kids with hemophilia and other bleeding disorders experience the fun of summer camp while making new friends. Cyronn appreciates the sense of community that Camp Wannaklot gave him, including "the opportunity to grow in my adult hemophiliac life."

In his free time, Cyronn enjoys playing video games, swimming, watching professional wrestling and creating content for his YouTube channel that recently surpassed 11,000 subscribers.

To learn more about the Aflac Cancer and Blood Disorders Center, including how to help, visit the Pediatric Cancer and Blood Disorder of Children's Healthcare of Atlanta website.

This article is for informational purposes only and is not a solicitation for insurance.

This article contains the opinions of Cyronn, who is an Aflac employee and is not intended to portray any specific benefits or details of Aflac insurance.

Aflac | Aflac New York | WWHQ 1932 Wynnton Road | Columbus, GA 31999

Z2500795
Exp 8/26


View additional multimedia and more ESG storytelling from Aflac Incorporated on 3blmedia.com.

Contact Info:
Spokesperson: Aflac Incorporated
Website: https://www.3blmedia.com/profiles/aflac-incorporated
Email: info@3blmedia.com

SOURCE: Aflac Incorporated



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/banking-and-financial-services/from-patient-to-lifelong-inspiration-aflac-employee-cyronn-herringto-1067817

© 2025 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.